Fri, February 18, 2022
Thu, February 17, 2022
Wed, February 16, 2022
Tue, February 15, 2022
Mon, February 14, 2022
Fri, February 11, 2022

John Newman Maintained (AGIO) at Strong Buy with Decreased Target to $44 on, Feb 16th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-44-on-feb-16th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

John Newman of Canaccord Genuity, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Strong Buy with Decreased Target from $52 to $44 on, Feb 16th, 2022.

John has made no other calls on AGIO in the last 4 months.



There are 3 other peers that have a rating on AGIO. Out of the 3 peers that are also analyzing AGIO, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andrew Berens of "SVB Leerink" Maintained at Hold with Decreased Target to $42 on, Thursday, November 18th, 2021


These are the ratings of the 2 analyists that currently disagree with John


  • Greg Harrison of "B of A Securities" Initiated at Strong Buy and Held Target at $54 on, Friday, December 3rd, 2021
  • Michael King of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $95 on, Thursday, November 4th, 2021

Publication Contributing Sources